Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • newbietonextgen
    Member
    • Nov 2010
    • 56

    Freebayes 0.9.9 problems

    Hello All,

    I am trying to run freebayes version 0.9.9 and am having problems. I am used pervious versions and never encountered these problems.

    The command is use:

    freebayes -XuiP 0.01 -f /path_to_fasta_file -b 40077_sorted_RG.bam -b 40079_sorted_RG.bam -v trial.freebayes.vcf

    The output on the terminal: (never seen it doing this before)

    GACAGGCCAGGCAGAACAGACGGCTGCTTCATGTCGTCTGTGTCTACAGCAGCTATTGCAAAGGCCCATCCGTACCCCCTGGGATCCTTGAAATGCCCCTTCGGACGTAATCCGTACCGAGTATGCACGGAGCCCCTGGGCCCGTCACGACGGGATGCTTCTGCCGCTCAGTTCAGCGAGGCTCATTTTGGCCTCCAGCGCAGTCAGTCCTTGAGAGCCCCCGTGCGCACCACGAACGCAAAGCCAAACATAGCAAAGACAAACAGGAACAGTACTGCGGCACCTCCCATTGCCGCTCCTCGTACCGACTGAGTCATTATTGCGAGAACTGTGGGCAGCGTTCCCAGACGGCTTTCCGACTACAAATGAGTGCTTTCGGACCCGCTGTGCCCACTGCGGCGTGCCGCTGTTTCTCAGCTTTCCGCCACGACCCCTCCGTGAGGTCCTCGCTAAGAAGAGCGCTC
    1:2179
    Aborted

    The Vcf file shows the first SNP at 1:2179 and then it stops. The bam files (read group, index, started) were used with GATK and worked fine. The output is the same even of i use one bam file to call SNPs

    So what am i doing wrong?
    Thanks
    newbie..
  • newbietonextgen
    Member
    • Nov 2010
    • 56

    #2
    a little bit of digging around and i see that an error is also posted...

    Error: Exception: Cannot read past the end of the alignment's sequence.


    So what does this mean? Any ideas?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    211 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...